[go: up one dir, main page]

HRP20070057T3 - 2-supstituirani pirimidini - Google Patents

2-supstituirani pirimidini

Info

Publication number
HRP20070057T3
HRP20070057T3 HR20070057T HRP20070057T HRP20070057T3 HR P20070057 T3 HRP20070057 T3 HR P20070057T3 HR 20070057 T HR20070057 T HR 20070057T HR P20070057 T HRP20070057 T HR P20070057T HR P20070057 T3 HRP20070057 T3 HR P20070057T3
Authority
HR
Croatia
Prior art keywords
alkyl
cyano
cycloalkyl
alkenyl
alkoxy
Prior art date
Application number
HR20070057T
Other languages
English (en)
Croatian (hr)
Inventor
Schw�gler Anja
Gewehr Markus
Mller Bernd
Grote Thomas
Grammenos Wassilios
Tormo I Blasco Jordi
Gypser Andreas
Rheinheimer Joachim
Blettner Carsten
Sch�fer Peter
Schieweck Frank
Wagner Oliver
Stierl Reinhard
Sch�fl Ulrich
Strathmann Siegfired
Scherer Maria
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of HRP20070057T3 publication Critical patent/HRP20070057T3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20070057T 2003-07-24 2004-07-15 2-supstituirani pirimidini HRP20070057T3 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10333857 2003-07-24
DE10357714 2003-12-09
PCT/EP2004/007877 WO2005012261A1 (de) 2003-07-24 2004-07-15 2-substituierte pyrimidine

Publications (1)

Publication Number Publication Date
HRP20070057T3 true HRP20070057T3 (hr) 2007-07-31

Family

ID=34117367

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20070057T HRP20070057T3 (hr) 2003-07-24 2004-07-15 2-supstituirani pirimidini

Country Status (30)

Country Link
US (1) US7375108B2 (es)
EP (1) EP1651618B1 (es)
JP (1) JP2006528603A (es)
KR (1) KR20060052857A (es)
AP (1) AP2157A (es)
AR (1) AR045100A1 (es)
AT (1) ATE350370T1 (es)
AU (1) AU2004261373B8 (es)
BR (1) BRPI0412891A (es)
CA (1) CA2532718A1 (es)
CO (1) CO5660292A2 (es)
CR (1) CR8184A (es)
CY (1) CY1106391T1 (es)
DE (1) DE502004002570D1 (es)
DK (1) DK1651618T3 (es)
EA (1) EA010566B1 (es)
EC (1) ECSP066278A (es)
ES (1) ES2279395T3 (es)
HR (1) HRP20070057T3 (es)
IL (1) IL172848A0 (es)
MA (1) MA27949A1 (es)
MX (1) MXPA06000038A (es)
NZ (1) NZ545103A (es)
PE (1) PE20050882A1 (es)
PL (1) PL1651618T3 (es)
PT (1) PT1651618E (es)
SI (1) SI1651618T1 (es)
TW (1) TW200516075A (es)
UY (1) UY28436A1 (es)
WO (1) WO2005012261A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080132522A1 (en) * 2004-07-14 2008-06-05 Basf Aktiengesellschaft 2-Substituted Pyrimidines, Method for Their Production and Their Use for Controlling Pathogenic Fungi
CL2007002231A1 (es) * 2006-08-02 2008-04-11 Basf Ag Uso de compuestos derivados de 5-(het) arilpirimidina para combatir hongos daninos; compuestos derivados de 5-(het) arilpirimidina; agente fungicida; y agente farmaceutico.
CN103429574B (zh) * 2010-11-16 2016-11-16 阿塞蒂隆制药公司 作为蛋白质去乙酰化酶抑制剂的嘧啶羟基酰胺化合物和其使用方法
JP6626437B2 (ja) 2013-10-08 2019-12-25 アセチロン ファーマシューティカルズ インコーポレイテッドAcetylon Pharmaceuticals,Inc. ヒストンデアセチラーゼ阻害剤とHer2阻害剤またはPI3K阻害剤のいずれかの組み合わせ
WO2015054474A1 (en) 2013-10-10 2015-04-16 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
WO2015061684A1 (en) 2013-10-24 2015-04-30 Mayo Foundation For Medical Education And Research Treatment of polycystic diseases with an hdac6 inhibitor
AU2014360544A1 (en) 2013-12-03 2016-07-21 Acetylon Pharmaceuticals, Inc. Combinations of histone deacetylase inhibitors and immunomodulatory drugs
US9464073B2 (en) 2014-02-26 2016-10-11 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
BR112017000301A2 (pt) 2014-07-07 2017-11-07 Acetylon Pharmaceuticals Inc tratamento de leucemia com inibidores de histona desacetilase
WO2016087950A1 (en) 2014-12-05 2016-06-09 University of Modena and Reggio Emilia Combinations of histone deacetylase inhibitors and bendamustine for use in the treatment of lymphoma
US10272084B2 (en) 2015-06-01 2019-04-30 Regenacy Pharmaceuticals, Llc Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
WO2017184774A1 (en) 2016-04-19 2017-10-26 Acetylon Pharmaceuticals, Inc. Hdac inhibitors, alone or in combination with btk inhibitors, for treating chronic lymphocytic leukemia
WO2018016596A1 (ja) * 2016-07-20 2018-01-25 国立大学法人東北大学 PPARαアゴニストを含有する、肺高血圧症の予防又は治療剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20024041A3 (cs) 2000-06-13 2003-04-16 Basf Aktiengesellschaft Fungicidní 5-fenyl substituované 2-(kyanamino) pyrimidiny
WO2002074753A2 (de) 2001-03-15 2002-09-26 Basf Aktiengesellschaft 5-phenylpyrimidine, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung zur bekaempfung von schadpilzen
CN1312134C (zh) 2001-11-19 2007-04-25 巴斯福股份公司 5-苯基嘧啶化合物、包含它们的组合物、其制备方法及其用途

Also Published As

Publication number Publication date
NZ545103A (en) 2008-06-30
WO2005012261A1 (de) 2005-02-10
AU2004261373B8 (en) 2010-11-04
ATE350370T1 (de) 2007-01-15
US20070105873A1 (en) 2007-05-10
DE502004002570D1 (de) 2007-02-15
MXPA06000038A (es) 2006-03-21
KR20060052857A (ko) 2006-05-19
TW200516075A (en) 2005-05-16
ECSP066278A (es) 2006-07-28
BRPI0412891A (pt) 2006-10-03
IL172848A0 (en) 2006-06-11
AU2004261373B2 (en) 2010-08-19
AU2004261373A1 (en) 2005-02-10
CA2532718A1 (en) 2005-02-10
ES2279395T3 (es) 2007-08-16
MA27949A1 (fr) 2006-06-01
DK1651618T3 (da) 2007-05-14
EA200600212A1 (ru) 2006-08-25
US7375108B2 (en) 2008-05-20
AP2006003497A0 (en) 2006-02-28
SI1651618T1 (sl) 2007-06-30
EA010566B1 (ru) 2008-10-30
PT1651618E (pt) 2007-03-30
AR045100A1 (es) 2005-10-12
AP2157A (en) 2010-09-13
CO5660292A2 (es) 2006-07-31
EP1651618B1 (de) 2007-01-03
PL1651618T3 (pl) 2007-05-31
EP1651618A1 (de) 2006-05-03
JP2006528603A (ja) 2006-12-21
CY1106391T1 (el) 2011-10-12
UY28436A1 (es) 2005-02-28
PE20050882A1 (es) 2005-12-01
CR8184A (es) 2006-10-06

Similar Documents

Publication Publication Date Title
HRP20070057T3 (hr) 2-supstituirani pirimidini
RU2500680C2 (ru) Новые замещенные пиридин-2-оны и пиридазин-3-оны
NZ590887A (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
TW200604175A (en) Ortho substituted aryl or heteroaryl amide compounds
EA200601847A1 (ru) Замещённые метиларил- или гетероариламидные соединения
NO20065830L (no) Substituerte 2-kinolyloksazoler som er anvendbare som PDE4-inhibitorer.
HRP20040977B1 (hr) Derivati n-[fenil(piperidin-2-il)metil]benzamida,postupak njihovog pripravljanja i primjena istih u terapiji
CY1109821T1 (el) Ενωσεις πιπεραζινης με ζιζανιοκτονα δραση
MX2009007605A (es) Mezclas fungicidas que comprenden 1-metilpirazol-4-ilcarboxanilida s sustituidas.
WO2005092858A3 (en) Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
NZ601967A (en) Pde10 inhibitors and related compositions and methods
HUP0402310A2 (hu) 1,6-Naftiridin-származékok mint antidiabetikumok és ezeket tartalmazó gyógyszerkészítmények
MXPA05010874A (es) Compuestos n-heterociclicos condensados y su uso como antagonistas del receptor del factor liberador de corticotropina.
JOP20190239A1 (ar) مركبات مثبطة لـ vmat2 وتركيبات منها
ATE463483T1 (de) 6-substituierte isochinolinderivate als rock-1- inhibitoren
ME02672B (me) Fenil-3-aza-bicikl0[3.1.0]heks-3-il-metanoni i njihova primena kao medikament
HRP20080175T3 (hr) Supstituirani 2-aminotetrtalini, namijenjeni preventivnom liječenju parkinsonove bolesti
IL115545A0 (en) Oxime ethers their preparation and use
MX2013002557A (es) Nuevos analogos de piperazina como antivirales de influenza de amplio espectro.
TW200610760A (en) 2-(pyridin-2-yl)pyrimidines and their use for controlling harmful fungi
EA201390374A1 (ru) Гетероциклические соединения для лечения или профилактики расстройств, вызываемых ослабленной нейротрансмиссией серотонина, норэпинефрина или допамина
JP2006528603A5 (es)
HRP20030797B1 (hr) Fungicidne kompozicije
MEP12108A (en) Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists